{"id":"NCT03843632","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)","officialTitle":"An Open-Label, Multicenter, Single-arm Study to Evaluate the Immunogenicity of VARIVAX™ in Healthy Russian Individuals 12 Months of Age and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-01","primaryCompletion":"2020-06-19","completion":"2020-06-19","firstPosted":"2019-02-18","resultsPosted":"2021-04-06","lastUpdate":"2021-04-06"},"enrollment":150,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Varicella"],"interventions":[{"type":"BIOLOGICAL","name":"VARIVAX™","otherNames":[]}],"arms":[{"label":"VARIVAX™","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to evaluate the immunogenicity and safety of VARIVAX™ vaccine in healthy Russian children, adolescents, and adults. No formal hypothesis was tested.","primaryOutcome":{"measure":"Varicella Zoster Virus (VZV) Antibody Response Rate at 6 Weeks Post Last Vaccination in Participants Who Were Seronegative at Baseline","timeFrame":"Adults and Adolescents: 6 weeks post Vaccination 2 (up to approximately 86 days), Children: 6 weeks post Vaccination 1 (up to approximately 43 days)","effectByArm":[{"arm":"VARIVAX Adults (18 to 75 Years)","deltaMin":100,"sd":null},{"arm":"VARIVAX™ Adolescents 13 to 17 Years of Age","deltaMin":100,"sd":null},{"arm":"VARIVAX™ Children 7 to 12 Years of Age","deltaMin":95.5,"sd":null},{"arm":"VARIVAX™ Children 12 Months to 6 Years of Age","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":11},"locations":{"siteCount":5,"countries":["Russia"]},"refs":{"pmids":["34702124","34473594"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":50},"commonTop":["Injection site pain","Body temperature increased","Headache","Injection site erythema","Injection site swelling"]}}